Catalyzed by a surge of activity in the late 1990s, advances in stem cell biology over the past decade have continued to accelerate at a rapid pace.  As such, there is a developing need for concurrent research in engineering technologies and bioprocessing which are integral to the progression of stem cell biomanufacturing.

The biomanufacturing industry is expanding with commercial development of stem cell products projected to be $10 billion within the next 6-8 years. The need for interdisciplinary training for stem cell biomanufacturing is due to the complexity of not only the science, but also the long-term impact and public policy concerns commonly associated with stem cells.

Our mission is to produce leaders in stem cell biomanufacturing & to transform the potential of stem cells into viable cellular technologies for the development of novel stem cell therapies and diagnositics.

Stem Cell Biomanufacturing IGERT graduate students are selected each fall semester for their first two years of graduate school.  Learn more.